Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.

@article{Hung2013OralHA,
  title={Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.},
  author={Yi-chih Hung and Che-Chen Lin and Tzu-Yuan Wang and Man-Ping Chang and Fung-Chang Sung and Ching-Chu Chen},
  journal={Diabetes/metabolism research and reviews},
  year={2013},
  volume={29 8},
  pages={673-9}
}
AIMS This study aimed to assess the risk of non-fatal cardiovascular events among patients with type 2 diabetes mellitus (T2DM) who are taking metformin, glimepiride or glyburide. MATERIALS AND METHODS Using the National Health Insurance Research database in Taiwan, this retrospective cohort study identified 1159 patients with newly diagnosed T2DM from 1998 to 2007, 30 years and older and without a history of cardiovascular disease at baseline. Patients with cancer, liver cirrhosis or chronic… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS